| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.027 | 0.5 |